The European Patent Office (EPO) upholds bit.bio’s patent for its dual genomic safe harbour technology, opti-ox™, securing the broadest possible claims for programming of pluripotent stem cells (PSCs) into any cell type. Much like how CRISPR transformed genome editing, opti-ox establishes a new paradigm for the safe, consistent, and scalable manufacture of iPSC-derived cells. The successful […]
SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that on September 17, 2024, the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) issued a decision to invalidate all claims in the 10,155,981 patent that 10x Genomics had previously asserted against […]
Irvine, CA — Zymo Research Corporation, a leader in innovative life science solutions, acknowledges the patent infringement lawsuit filed by Qiagen GmbH on August 20, 2024, at the US District Court for the Central District of California regarding its MAGicBead cfDNA isolation technology. Zymo Research respects intellectual property rights and is confident that this technology represents […]
SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that on September 17, 2024, the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) issued a decision to invalidate all claims in the 10,155,981 patent that 10x Genomics had previously asserted […]
Irvine, CA — Zymo Research Corporation, a leader in innovative life science solutions, acknowledges the patent infringement lawsuit filed by Qiagen GmbH on August 20, 2024, at the US District Court for the Central District of California regarding its MAGicBead cfDNA isolation technology. Zymo Research respects intellectual property rights and is confident that this technology […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, welcomes the European Court of Justice’s (ECJ’s) judgment today ruling that the European Commission did not have jurisdiction over Illumina’s acquisition of GRAIL. Today’s judgment confirms Illumina’s longstanding view that the European Commission exceeded its authority by asserting jurisdiction over this […]
Biolin Scientific is pleased to announce the recent approval of a groundbreaking patent, highlighting the sophisticated temperature control capabilities of the QSense Omni instrument. Temperature regulation is critical in QCM-D measurements, and Biolin Scientific has consistently delivered industry-leading solutions in this area. To further solidify our position, we have developed an innovative method that maintains […]
The patent at issue was ruled invalid by the German Federal Patent Court in May 2024 BILLERICA, Mass. — Bruker Corporation (Nasdaq: BRKR) today announced that it has posted a bond, as authorized by the Munich Higher Regional Court, in order to suspend an injunction that had been impacting sales of CosMx™ Spatial Molecular Imager (SMI) […]
UPPSALA, Sweden — The biotech tools company MAGic™ BioProcessing, announces that both USA and China have granted patent rights to the patent of combinatory separation system for the MAGic™ Accio, the seamlessly scalable magnetic separator. The patent underscores MAGic™ BioProcessing’s dedication to push the boundaries of innovation in the field of separation technology and solidifies our cutting-edge biotechnological solutions resulting in: […]
CAMBRIDGE, England – biomodal, an omics-based life sciences technology and analytics company, today announced it has filed a lawsuit against New England Biolabs (“NEB”) in the United States District Court for the District of Massachusetts. The lawsuit seeks damages and a court order to stop NEB from making, using, selling, or offering for sale all […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
